Business Context and Reporting Period
This Form 6-K filing by Mainz Biomed N.V. (referred to in metadata as Quantum Cyber N.V.) covers the month of November 2023. The report details a Registered Direct Offering completed on November 13, 2023, with an anticipated closing date of November 15, 2023.
Key Financial Metrics
- Gross Proceeds: Approximately $5 million.
- Net Proceeds: Approximately $4.5 million after deducting placement agent fees and offering expenses.
- Placement Agent Fees: 7.0% of gross proceeds plus expense reimbursement up to $90,000.
- Debt Settlement: Portions of proceeds are designated to settle obligations under promissory notes issued on June 28, 2023.
- Liquidity Use: Remaining net proceeds are intended for working capital purposes.
Material Changes and Offering Structure
The company entered into a Securities Purchase Agreement to sell the following securities to institutional investors:
- Ordinary Shares: 3,359,655 shares at $1.20 per share.
- Pre-Funded Warrants: 805,012 warrants pre-funded at $1.18, exercisable for one Ordinary Share upon payment of a $0.02 nominal exercise price.
- Common Warrants: Warrants to purchase up to 4,166,667 Ordinary Shares at an exercise price of $1.20 per share, with a 5-year term.
The filing text does not provide comparative revenue, profit, or margin data for the prior period, as this is a current report regarding a capital raise rather than a periodic financial statement.
Guidance, Risks, and Restrictions
- Lock-Up Periods: The company agreed not to issue or announce the issuance of Common Stock for 30 days following the closing, with exceptions for the conversion of promissory notes.
- Variable Rate Transactions: The company is restricted from entering into variable rate transactions for one year following the closing.
- ATM Facility: After a 90-day period post-closing, the company may resume issuing Ordinary Shares via an "at the market" offering under an existing agreement with Cantor Fitzgerald & Co.
- Contingencies: Closing is subject to the satisfaction of customary conditions contained in the Securities Purchase Agreement.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds received.
- Confirm the exact amount of promissory notes settled with the offering proceeds.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific representations and warranties.
- Monitor the 30-day and 90-day lock-up expiration dates for potential future dilution.
- Check subsequent filings for the exercise status of the Pre-Funded Warrants and Common Warrants.